Analyze Diet
The Biochemical journal1983; 211(1); 243-250; doi: 10.1042/bj2110243

Use of procainamide gels in the purification of human and horse serum cholinesterases.

Abstract: Two large-scale methods based primarily on the use of procainamide-Sepharose gels were developed for the purification of horse and human serum non-specific cholinesterases. With method I, the procainamide-Sepharose 4B gel was used in the first step to handle large volumes of serum. With method II, the procainamide-Sepharose 4B gel was used in the final step to obtain pure enzyme. Although both methods gave electrophoretically pure cholinesterase preparations in good yields, they were significantly more efficient at purifying the horse enzyme than the human enzyme. To study this problem, the relative binding of human and horse cholinesterases to procainamide-, methylacridinium (MAC)-, m-trimethylammoniophenyl (m-PTA)- and p-trimethylammoniophenyl (p-PTA)-Sepharose 4B gels were measured, by using two approaches. In one, binding was measured by a procedure involving equilibration of pure cholinesterase in a small volume of diluted gel slurry (4%, v/v). A partially purified preparation of Electrophorus acetylcholinesterase was included. Pure human cholinesterase bound consistently more tightly to each of the gels than did horse cholinesterase, and the acetylcholinesterase appeared to bind the gels 10-100 times more tightly than did the non-specific cholinesterases. The order of binding for the cholinesterases, beginning with the tightest, was: procainamide-Sepharose 4B, MAC-Sepharose 4B, p-PTA-Sepharose 4B and m-PTA-Sepharose 4B. For the acetylcholinesterase the order was: MAC-Sepharose 4B, procainamide-Sepharose 4B, p-PTA-Sepharose 4B and m-PTA-Sepharose 4B. The second approach involved passing native sera or partially purified sera fractions through 1 ml test columns of each of the four affinity gels to determine their retention capacity for the cholinesterases. With these impure samples, the MAC-Sepharose 4B gels proved superior to the procainamide-Sepharose 4B gels at retaining human cholinesterase, but the opposite was true for the horse cholinesterase.
Publication Date: 1983-04-01 PubMed ID: 6870822PubMed Central: PMC1154348DOI: 10.1042/bj2110243Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the development of two methods using procainamide-Sepharose gels for the purification of human and horse serum cholinesterases, enzymes involved in nerve function. The study concludes that these methods are more effective for purifying horse cholinesterase than human cholinesterase.

Methods Developed

  • The researchers developed two large-scale purification methods primarily using procainamide-Sepharose gels.
  • The first method (Method I) employs procainamide-Sepharose 4B gel in the initial purification step to handle and process large volumes of serum.
  • The second method (Method II) uses the same gel but in the final step to obtain a pure enzyme.

Effectiveness of Methods

  • Both methods were capable of producing electrophoretically pure cholinesterase preparations in good yields.
  • However, they were significantly more efficient at purifying the enzyme from horse serum compared to human serum.

Experimentation with Different Gels

  • In the interest of investigating this disparity, they carried out tests measuring the relative binding of human and horse cholinesterases to four different gels: procainamide-Sepharose 4B, methylacridinium (MAC)-Sepharose 4B, m-trimethylammoniophenyl-Sepharose 4B, and p-trimethylammoniophenyl-Sepharose 4B.
  • Pure human cholinesterase bound consistently more tightly to each of the gels than its horse counterpart. Furthermore, an enzyme called acetylcholinesterase also appeared to bind these gels 10-100 times more tightly than the non-specific cholinesterases.

Binding Rankings

  • The researchers established a binding order for each enzyme according to the tightness of their bonding, with procainamide-Sepharose 4B appearing to be the strongest for cholinesterases but the MAC-Sepharose 4B proving to be the preferred gel for acetylcholinesterase.

Comparison of the Gels

  • Additionally, using a second approach which involved testing impure samples, the results indicated that MAC-Sepharose 4B gels were superior to procainamide-Sepharose 4B gels at retaining human cholinesterase. Yet, the procainamide-Sepharose 4B gels worked better for horse cholinesterase.

Cite This Article

APA
Ralston JS, Main AR, Kilpatrick BF, Chasson AL. (1983). Use of procainamide gels in the purification of human and horse serum cholinesterases. Biochem J, 211(1), 243-250. https://doi.org/10.1042/bj2110243

Publication

ISSN: 0264-6021
NlmUniqueID: 2984726R
Country: England
Language: English
Volume: 211
Issue: 1
Pages: 243-250

Researcher Affiliations

Ralston, J S
    Main, A R
      Kilpatrick, B F
        Chasson, A L

          MeSH Terms

          • Acetylcholinesterase / isolation & purification
          • Animals
          • Chemical Phenomena
          • Chemistry
          • Cholinesterases / blood
          • Cholinesterases / isolation & purification
          • Chromatography, Affinity / methods
          • Horses
          • Humans
          • Procainamide

          Grant Funding

          • ES-00044 / NIEHS NIH HHS
          • ES-07046 / NIEHS NIH HHS

          References

          This article includes 13 references
          1. Haupt H, Heide K, Zwisler O, Schwick HG. [Isolation and physico-chemical characterization of cholinesterase in human serum].. Blut 1966 Nov;14(2):65-75.
            pubmed: 5928504doi: 10.1007/BF01633493google scholar: lookup
          2. Das PK, Liddell J. Purification and properties of human serum cholinesterase.. Biochem J 1970 Mar;116(5):875-81.
            pubmed: 5441375doi: 10.1042/bj1160875google scholar: lookup
          3. Kalderon N, Silman I, Blumberg S, Dudai Y. A method for the purification of acetylcholinesterase by affinity chromatography.. Biochim Biophys Acta 1970 Jun 23;207(3):560-2.
            pubmed: 5452681doi: 10.1016/s0005-2795(70)80020-4google scholar: lookup
          4. Main AR, Tarkan E, Aull JL, Soucie WG. Purification of horse serum cholinesterase by preparative polyacrylamide gel electrophoresis.. J Biol Chem 1972 Jan 25;247(2):566-71.
            pubmed: 5009701
          5. Rosenberry TL, Chang HW, Chen YT. Purification of acetylcholinesterase by affinity chromatography and determination of active site stoichiometry.. J Biol Chem 1972 Mar 10;247(5):1555-65.
            pubmed: 5012324
          6. Dudai Y, Silman I, Kalderon N, Blumberg S. Purification by affinity chromatography of acetylcholinesterase from electric organ tissue of the electric eel subsequent to tryptic treatment.. Biochim Biophys Acta 1972 Apr 7;268(1):138-57.
            pubmed: 5018273doi: 10.1016/0005-2744(72)90208-2google scholar: lookup
          7. Dudai Y, Silman I, Shinitzky M, Blumberg S. Purification by affinity chromatography of the molecular forms of acetylcholinesterase present in fresh electric-organ tissue of electric eel.. Proc Natl Acad Sci U S A 1972 Sep;69(9):2400-3.
            pubmed: 4506759doi: 10.1073/pnas.69.9.2400google scholar: lookup
          8. Dudai Y, Silman I. Affinity chromatography of acetylcholinesterase.. Methods Enzymol 1974;34:571-80.
            pubmed: 4449474doi: 10.1016/s0076-6879(74)34076-1google scholar: lookup
          9. Main AR, Soucie WG, Buxton IL, Arinc E. The purification of cholinesterase from horse serum.. Biochem J 1974 Dec;143(3):733-44.
            pubmed: 4462752doi: 10.1042/bj1430733google scholar: lookup
          10. Muensch H, Goedde HW, Yoshida A. Human-serum cholinesterase subunits and number of active sites of the major component.. Eur J Biochem 1976 Nov 1;70(1):217-23.
          11. Lockridge O, La Du BN. Comparison of atypical and usual human serum cholinesterase. Purification, number of active sites, substrate affinity, and turnover number.. J Biol Chem 1978 Jan 25;253(2):361-6.
            pubmed: 618874
          12. Main AR, McKnelly SC, Burgess-Miller SK. A subunit-sized butyrylcholinesterase present in high concentrations in pooled rabbit serum.. Biochem J 1977 Nov 1;167(2):367-76.
            pubmed: 597249doi: 10.1042/bj1670367google scholar: lookup
          13. ELLMAN GL, COURTNEY KD, ANDRES V Jr, FEATHER-STONE RM. A new and rapid colorimetric determination of acetylcholinesterase activity.. Biochem Pharmacol 1961 Jul;7:88-95.
            pubmed: 13726518doi: 10.1016/0006-2952(61)90145-9google scholar: lookup

          Citations

          This article has been cited 16 times.
          1. Mirbabaei F, Mohammad-Khah A, Naseri MT, Babri M, Faraz SM, Hosseini SE, Ashrafi D. Unambiguous identification and determination of A234-Novichok nerve agent biomarkers in biological fluids using GC-MS/MS and LC-MS/MS. Anal Bioanal Chem 2022 May;414(11):3429-3442.
            doi: 10.1007/s00216-022-03964-1pubmed: 35190842google scholar: lookup
          2. Rosenberg Y, Saxena A. Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs. Neuropharmacology 2020 Sep 1;174:108150.
          3. Zhang L, Baker SL, Murata H, Harris N, Ji W, Amitai G, Matyjaszewski K, Russell AJ. Tuning Butyrylcholinesterase Inactivation and Reactivation by Polymer-Based Protein Engineering. Adv Sci (Weinh) 2020 Jan;7(1):1901904.
            doi: 10.1002/advs.201901904pubmed: 31921563google scholar: lookup
          4. Lockridge O, David E, Schopfer LM, Masson P, Brazzolotto X, Nachon F. Purification of recombinant human butyrylcholinesterase on Hupresin®. J Chromatogr B Analyt Technol Biomed Life Sci 2018 Dec 1;1102-1103:109-115.
            doi: 10.1016/j.jchromb.2018.10.026pubmed: 30384187google scholar: lookup
          5. Corbin JM, Kailemia MJ, Cadieux CL, Alkanaimsh S, Karuppanan K, Rodriguez RL, Lebrilla CB, Cerasoli DM, McDonald KA, Nandi S. Purification, characterization, and N-glycosylation of recombinant butyrylcholinesterase from transgenic rice cell suspension cultures. Biotechnol Bioeng 2018 May;115(5):1301-1310.
            doi: 10.1002/bit.26557pubmed: 29411865google scholar: lookup
          6. Dafferner AJ, Lushchekina S, Masson P, Xiao G, Schopfer LM, Lockridge O. Characterization of butyrylcholinesterase in bovine serum. Chem Biol Interact 2017 Mar 25;266:17-27.
            doi: 10.1016/j.cbi.2017.02.004pubmed: 28189703google scholar: lookup
          7. Chen X, Zheng X, Zhan M, Zhou Z, Zhan CG, Zheng F. Metabolic Enzymes of Cocaine Metabolite Benzoylecgonine. ACS Chem Biol 2016 Aug 19;11(8):2186-94.
            doi: 10.1021/acschembio.6b00277pubmed: 27224254google scholar: lookup
          8. Hou S, Zhan M, Zheng X, Zhan CG, Zheng F. Kinetic characterization of human butyrylcholinesterase mutants for the hydrolysis of cocaethylene. Biochem J 2014 Jun 15;460(3):447-57.
            doi: 10.1042/BJ20140360pubmed: 24870023google scholar: lookup
          9. Zhan M, Hou S, Zhan CG, Zheng F. Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine. Biochem J 2014 Jan 1;457(1):197-206.
            doi: 10.1042/BJ20131100pubmed: 24125115google scholar: lookup
          10. Biberoglu K, Schopfer LM, Tacal O, Lockridge O. The proline-rich tetramerization peptides in equine serum butyrylcholinesterase. FEBS J 2012 Oct;279(20):3844-58.
          11. Ralph EC, Xiang L, Cashman JR, Zhang J. His-tag truncated butyrylcholinesterase as a useful construct for in vitro characterization of wild-type and variant butyrylcholinesterases. Protein Expr Purif 2011 Nov;80(1):22-7.
            doi: 10.1016/j.pep.2011.07.005pubmed: 21802514google scholar: lookup
          12. Kim JH, Stevens RC, MacCoss MJ, Goodlett DR, Scherl A, Richter RJ, Suzuki SM, Furlong CE. Identification and characterization of biomarkers of organophosphorus exposures in humans. Adv Exp Med Biol 2010;660:61-71.
            doi: 10.1007/978-1-60761-350-3_7pubmed: 20221871google scholar: lookup
          13. Lockridge O, Schopfer LM, Winger G, Woods JH. LARGE SCALE PURIFICATION OF BUTYRYLCHOLINESTERASE FROM HUMAN PLASMA SUITABLE FOR INJECTION INTO MONKEYS; A POTENTIAL NEW THERAPEUTIC FOR PROTECTION AGAINST COCAINE AND NERVE AGENT TOXICITY. J Med Chem Biol Radiol Def 2005 Jul 1;3:nihms5095.
            doi: 10.1901/jaba.2005.3-nihms5095pubmed: 16788731google scholar: lookup
          14. Kovarik Z, Radić Z, Berman HA, Simeon-Rudolf V, Reiner E, Taylor P. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates. Biochem J 2003 Jul 1;373(Pt 1):33-40.
            doi: 10.1042/BJ20021862pubmed: 12665427google scholar: lookup
          15. Thompson HM. Development of an immunoassay for avian serum butyrylcholinesterase and its use in assessing exposure to organophosphorus and carbamate pesticides. Bull Environ Contam Toxicol 1995 Feb;54(2):237-44.
            doi: 10.1007/BF00197436pubmed: 7742632google scholar: lookup
          16. Sonmez G, Karatas BE, Bodur E. From Crude Extracts to Purity: A Comparative Study of Butyrylcholinesterase Purification. Protein J 2025 Jun;44(3):259-267.
            doi: 10.1007/s10930-025-10248-xpubmed: 39920532google scholar: lookup